Since the current experiment demonstrated that the molar concentration ratio of free plasma IL-18BP/IL-18 was 9.93 in the patient with eczema, it seems likely not enough IL-18BP to inhibit proinflammatory actions of IL-18 in eczema. This evidence concerns the gene IL18BP and Eczematoid dermatitis.